Javier Noguera-Garde - Publications

First-line osimertinib in advanced EGFR-mutated NSCLC: real-world outcomes, clinicogenomic correlates, and oligoprogression management in a multicenter Spanish cohort.

Journal: ESMO real world data and digital oncology

Published: July 01, 2026

The Impact on the Therapeutic Decision of Massive Gene Sequencing (NGS) in Plasma from Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).

Journal: Cancers

Published: September 28, 2025

Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: May 09, 2025

Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial.

Journal: The Lancet. Oncology

Published: May 08, 2025

Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial.

Journal: Nature medicine

Published: March 12, 2025

A real‑world study of clinical characteristics, treatment sequence and outcomes of patients with non-small cell lung cancer and EGFR exon 20 insertion mutations.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 20, 2024

Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer.

Journal: JCO precision oncology

Published: January 07, 2022

Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy.

Journal: Cancers

Published: June 30, 2021

Current treatment landscape for oligometastatic non-small cell lung cancer.

Journal: World journal of clinical oncology

Published: April 25, 2021

Impact of SARS-CoV-2 Infection on Patients with Cancer: Retrospective and Transversal Studies in Spanish Population.

Journal: Cancers

Published: November 09, 2020

Stereotactic body radiation therapy: A good dance partner of oligometastatic non-small cell lung cancer to the sound of SINDAS study.

Journal: World journal of clinical oncology

Published: July 25, 2020

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design.

Journal: Contemporary clinical trials communications

Published: July 13, 2020